Literature DB >> 1913116

Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil.

J T Plukker1, N H Mulder, D T Sleijfer, J Grond, R C Verschueren.   

Abstract

Locally advanced cancer of the cardia and fundus might be cured by surgical resection. Poor results after surgery in stage IIIB and stage IV disease prompted a study of neoadjuvant chemotherapy. Treatment included four cycles of high doses of methotrexate (1.5 g/m2) and high doses of 5-fluorouracil (1.5 g/m2) followed by surgery in those patients with lesions then found to be resectable. Twenty patients with tumours staged as IIIB or IV were entered; 17 patients completed the four courses of chemotherapy and 14 underwent re-exploration. Eight patients achieved tumour reduction enabling resection. Five patients underwent total gastrectomy with distal pancreatectomy and splenectomy en bloc and three patients had an oesophagogastrectomy. There were no treatment-related deaths and toxicity was tolerable. Two patients were alive 54 and 41 months after chemotherapy with no evidence of disease. Locoregional recurrence developed in five patients and metastatic disease in one. Their median survival was 22 months.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1913116     DOI: 10.1002/bjs.1800780820

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  18 in total

1.  Neoadjuvant therapy.

Authors:  J E Niederhuber
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

Review 2.  Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives.

Authors:  Alberto Biondi; Maria C Lirosi; Domenico D'Ugo; Valeria Fico; Riccardo Ricci; Francesco Santullo; Antonia Rizzuto; Ferdinando Cm Cananzi; Roberto Persiani
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

3.  Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer.

Authors:  A M Lowy; P F Mansfield; S D Leach; R Pazdur; P Dumas; J A Ajani
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

4.  Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate.

Authors:  Markus Menges; Carsten Schmidt; Werner Lindemann; Karsten Ridwelski; Werner Pueschel; Bernhard Jüngling; Gernot Feifel; Martin Schilling; Andreas Stallmach; Martin Zeitz
Journal:  J Cancer Res Clin Oncol       Date:  2003-06-27       Impact factor: 4.553

Review 5.  Preoperative chemotherapy for unresectable gastric cancer.

Authors:  H Wilke; M Stahl; U Fink; H J Meyer; J R Siewert
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

6.  Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication.

Authors:  Yanlei Ma; Huanlong Qin; Qi Zheng; Yu Wang; Zhiguo Wang; Zhe Yang
Journal:  Med Oncol       Date:  2009-11-03       Impact factor: 3.064

7.  p53 protein overexpression as a predictor of the response to chemotherapy in gastric cancer.

Authors:  B Nakata; K H Chung; M Ogawa; Y Ogawa; K Yanagawa; K Muguruma; T Inoue; Y Yamashita; N Onoda; K Maeda; T Sawada; M Sowa
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

Review 8.  Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction.

Authors:  Markus Menges; Thomas Hoehler
Journal:  J Cancer Res Clin Oncol       Date:  2008-06-04       Impact factor: 4.553

Review 9.  Gastric carcinoma.

Authors:  Alexandria T Phan; Jaffer A Ajani
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

Review 10.  Neoadjuvant Therapy of Gastric Cancer: A Decisive Step Forward.

Authors:  Markus Menges; Thomas Hoehler
Journal:  Gastrointest Tumors       Date:  2014-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.